Review



polyclonal goat igg antibody against caiv  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    R&D Systems polyclonal goat igg antibody against caiv
    <t>CAIV</t> immunostaining of reproductive organs in nonpregnant mice. a–d Ovary. No immunostaining is visible in the mullerian epithelium (ME in a ), ovarian stroma (S in a ), primordial follicles (arrow in a ), primary follicles (* in b ), secondary follicles (SF in b ), tertiary follicles ( c ), and corpora lutea ( d ). e , f Fallopian tube. Neither in the ampulla ( e ) nor in the isthmus ( f ) is CAIV immunostaining observed in the epithelium (Ep) and musculature (M). In the uterus ( g ), endometrial capillaries were CAIV immunoreactive (insert in g ), while no staining is visible in the endometrial epithelium (Ep) and the endometrial stromal cells (S). h Vagina. In the vaginal tissue, no CAIV-immunoreactive cells are observed in the epithelium (Ep) or in the stroma (S). i In kidney as positive control, a strong CAIV signal is visible in tubular epithelium while the negative control of the endometrium ( j ) shows no immunostaining (counterstaining with hematoxylin). Bar, 50 μm.
    Polyclonal Goat Igg Antibody Against Caiv, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 78 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+caiv+antibody/Mouse+Carbonic+Anhydrase+IV%2FCA4+Antibody/pmc12060823-69-15-22
    Average 95 stars, based on 78 article reviews
    polyclonal goat igg antibody against caiv - by Bioz Stars, 2026-09
    95/100 stars

    Images

    1) Product Images from "Carbonic Anhydrase IV Deficiency Causes Intrauterine Embryonic Loss in Mice"

    Article Title: Carbonic Anhydrase IV Deficiency Causes Intrauterine Embryonic Loss in Mice

    Journal: Cells, Tissues, Organs

    doi: 10.1159/000544000

    CAIV immunostaining of reproductive organs in nonpregnant mice. a–d Ovary. No immunostaining is visible in the mullerian epithelium (ME in a ), ovarian stroma (S in a ), primordial follicles (arrow in a ), primary follicles (* in b ), secondary follicles (SF in b ), tertiary follicles ( c ), and corpora lutea ( d ). e , f Fallopian tube. Neither in the ampulla ( e ) nor in the isthmus ( f ) is CAIV immunostaining observed in the epithelium (Ep) and musculature (M). In the uterus ( g ), endometrial capillaries were CAIV immunoreactive (insert in g ), while no staining is visible in the endometrial epithelium (Ep) and the endometrial stromal cells (S). h Vagina. In the vaginal tissue, no CAIV-immunoreactive cells are observed in the epithelium (Ep) or in the stroma (S). i In kidney as positive control, a strong CAIV signal is visible in tubular epithelium while the negative control of the endometrium ( j ) shows no immunostaining (counterstaining with hematoxylin). Bar, 50 μm.
    Figure Legend Snippet: CAIV immunostaining of reproductive organs in nonpregnant mice. a–d Ovary. No immunostaining is visible in the mullerian epithelium (ME in a ), ovarian stroma (S in a ), primordial follicles (arrow in a ), primary follicles (* in b ), secondary follicles (SF in b ), tertiary follicles ( c ), and corpora lutea ( d ). e , f Fallopian tube. Neither in the ampulla ( e ) nor in the isthmus ( f ) is CAIV immunostaining observed in the epithelium (Ep) and musculature (M). In the uterus ( g ), endometrial capillaries were CAIV immunoreactive (insert in g ), while no staining is visible in the endometrial epithelium (Ep) and the endometrial stromal cells (S). h Vagina. In the vaginal tissue, no CAIV-immunoreactive cells are observed in the epithelium (Ep) or in the stroma (S). i In kidney as positive control, a strong CAIV signal is visible in tubular epithelium while the negative control of the endometrium ( j ) shows no immunostaining (counterstaining with hematoxylin). Bar, 50 μm.

    Techniques Used: Immunostaining, Staining, Positive Control, Negative Control

    CAIV immunostaining of mouse embryos at developmental stages 4.5 ( a ), 5.5 ( b ), 6.5 ( c ), and 7.5 dpc ( d ). CAIV immunoreactivity is visible in the blastocyst (B), the visceral endoderm (VE), and the embryonic ectoderm (IE). Corresponding negative controls ( a ′, b ′, c ′, d ′) show no immunostaining. Slides are counterstained with hematoxylin. Bar, 50 μm in a , b , 100 μm in c , d , 100 μm in a ′, b ′, and 160 μm in c ′, d ′.
    Figure Legend Snippet: CAIV immunostaining of mouse embryos at developmental stages 4.5 ( a ), 5.5 ( b ), 6.5 ( c ), and 7.5 dpc ( d ). CAIV immunoreactivity is visible in the blastocyst (B), the visceral endoderm (VE), and the embryonic ectoderm (IE). Corresponding negative controls ( a ′, b ′, c ′, d ′) show no immunostaining. Slides are counterstained with hematoxylin. Bar, 50 μm in a , b , 100 μm in c , d , 100 μm in a ′, b ′, and 160 μm in c ′, d ′.

    Techniques Used: Immunostaining

    CAIV immunostaining of a representative mouse embryo at 8.5 dpc in overview ( a ) and in higher magnification ( b , c ). A strong immunoreactivity is visible in the amniotic membrane (AM), the yolk sac epithelium (Y), trophoblast giant cells (TGC), the endometrial epithelium (EE), and the developing GT of the embryo (E). Corresponding negative controls ( a ′, b ′, c ′) show no immunostaining. Slides are counterstained with hematoxylin. Bar indicates 200 μm in a and 50 μm in b , c .
    Figure Legend Snippet: CAIV immunostaining of a representative mouse embryo at 8.5 dpc in overview ( a ) and in higher magnification ( b , c ). A strong immunoreactivity is visible in the amniotic membrane (AM), the yolk sac epithelium (Y), trophoblast giant cells (TGC), the endometrial epithelium (EE), and the developing GT of the embryo (E). Corresponding negative controls ( a ′, b ′, c ′) show no immunostaining. Slides are counterstained with hematoxylin. Bar indicates 200 μm in a and 50 μm in b , c .

    Techniques Used: Immunostaining, Membrane

    CAIV immunostaining of mouse embryos at 9.5 dpc in overview ( a , b ) and in higher magnification ( c–h ). Within the developing embryo ( c , d ), CAIV immunostaining is visible in the gut tube (GT), the floor plate of the neural tube (FP), and the notochord (N). In placenta and extraembryonic tissues ( e–h ), the labyrinthine compartment (LT), the endometrial epithelium (EE), the trophoblast giant cells (TGC), and the yolk sac epithelium (Y) show immunoreactivity. The corresponding negative control ( b ) shows no immunostaining (counterstaining with hematoxylin). Bar = 500 μm in a , b and 50 μm in c–h .
    Figure Legend Snippet: CAIV immunostaining of mouse embryos at 9.5 dpc in overview ( a , b ) and in higher magnification ( c–h ). Within the developing embryo ( c , d ), CAIV immunostaining is visible in the gut tube (GT), the floor plate of the neural tube (FP), and the notochord (N). In placenta and extraembryonic tissues ( e–h ), the labyrinthine compartment (LT), the endometrial epithelium (EE), the trophoblast giant cells (TGC), and the yolk sac epithelium (Y) show immunoreactivity. The corresponding negative control ( b ) shows no immunostaining (counterstaining with hematoxylin). Bar = 500 μm in a , b and 50 μm in c–h .

    Techniques Used: Immunostaining, Negative Control

    Litter size and sex distribution in heterozygous and CAIV knockout mating. a Mating of CAIV knockout mice ( n = 17 litters) results in a significant reduction of litter size compared to heterozygous mating ( n = 31 litters). b Homozygous CAIV knockout mating results in a non-mendalian sex distribution of the 54 CAIV knockout pubs analyzed (74% male and 26% female instead of 50% each). c In heterozygous mating, the 164 pups analyzed show an enhanced number of wild-type (31% instead of 25% expected) and heterozygous genotype (62% instead of 50% expected), whereas the number of CAIV knockout pups is significantly reduced (7% instead of 25% expected). d A non-mendelian sex distribution is also observed in the 12 CAIV knockout pups (shown in c ) resulting from heterozygous mating (67% male and 33% female instead of 50% each), while there is a slight preponderance of female pups in both the 50 resulting wild-type (36% male vs. 64% female) and the 102 resulting CAIV heterozygous pups (46% male vs. 54% female). e On 9.5 dpc, number of implantation chambers is similar in heterozygous ( n = 3) and CAIV knockout ( n = 5) mating. The sex distribution of embryos is slightly shifted to female in both experimental groups, showing a higher percentage of female embryos in heterozygous mating in total ( n = 26; 40% male vs. 60% female) as well as in CAIV knockout embryos resulting from heterozygous mating (40% male vs. 60% female). f Additionally, CAIV knockout mating results in a higher percentage of female embryos on day 9.5 of pregnancy ( n = 21; 43% male vs. 57% female).
    Figure Legend Snippet: Litter size and sex distribution in heterozygous and CAIV knockout mating. a Mating of CAIV knockout mice ( n = 17 litters) results in a significant reduction of litter size compared to heterozygous mating ( n = 31 litters). b Homozygous CAIV knockout mating results in a non-mendalian sex distribution of the 54 CAIV knockout pubs analyzed (74% male and 26% female instead of 50% each). c In heterozygous mating, the 164 pups analyzed show an enhanced number of wild-type (31% instead of 25% expected) and heterozygous genotype (62% instead of 50% expected), whereas the number of CAIV knockout pups is significantly reduced (7% instead of 25% expected). d A non-mendelian sex distribution is also observed in the 12 CAIV knockout pups (shown in c ) resulting from heterozygous mating (67% male and 33% female instead of 50% each), while there is a slight preponderance of female pups in both the 50 resulting wild-type (36% male vs. 64% female) and the 102 resulting CAIV heterozygous pups (46% male vs. 54% female). e On 9.5 dpc, number of implantation chambers is similar in heterozygous ( n = 3) and CAIV knockout ( n = 5) mating. The sex distribution of embryos is slightly shifted to female in both experimental groups, showing a higher percentage of female embryos in heterozygous mating in total ( n = 26; 40% male vs. 60% female) as well as in CAIV knockout embryos resulting from heterozygous mating (40% male vs. 60% female). f Additionally, CAIV knockout mating results in a higher percentage of female embryos on day 9.5 of pregnancy ( n = 21; 43% male vs. 57% female).

    Techniques Used: Knock-Out

    Related Articles

    Expressing:

    Article Title: Nasal ciliary beating controlled by carbonic anhydrase IV and Na+/HCO3- co-transport under an extremely low CO2 condition (air)
    Article Snippet: .. The protein expression of CAIV was also examined in c-hNECs and c-hBECs using anti-CAIV antibody (MAB2186, R&D System) by western blotting (WB). ..

    Western Blot:

    Article Title: Nasal ciliary beating controlled by carbonic anhydrase IV and Na+/HCO3- co-transport under an extremely low CO2 condition (air)
    Article Snippet: .. The protein expression of CAIV was also examined in c-hNECs and c-hBECs using anti-CAIV antibody (MAB2186, R&D System) by western blotting (WB). ..

    Blocking Assay:

    Article Title: Nasal ciliary beating controlled by carbonic anhydrase IV and Na+/HCO3- co-transport under an extremely low CO2 condition (air)
    Article Snippet: .. We used a blocking peptide for the anti-CAIV antibody (2186-CA, R&D System). ..

    Recombinant:

    Article Title: Nasal ciliary beating controlled by carbonic anhydrase IV and Na+/HCO3- co-transport under an extremely low CO2 condition (air)
    Article Snippet: Penicillin/streptomycin mixed solution (penicillin 10000 units/mL and streptomycin 10000 μg/mL in 0.85% NaCl), trypsin, and the trypsin inhibitor were purchased from Nacalai Tesque, Inc. (Kyoto, Japan). .. Antibodies The anti-CAIV antibody (MAB2186, mouse antibody directed against recombinant human CAIV (rhCA4; aa 19-283)) was purchased from R&D Systems (Minneapolis, MN, USA). ..



    Similar Products

    95
    R&D Systems polyclonal goat igg antibody against caiv
    <t>CAIV</t> immunostaining of reproductive organs in nonpregnant mice. a–d Ovary. No immunostaining is visible in the mullerian epithelium (ME in a ), ovarian stroma (S in a ), primordial follicles (arrow in a ), primary follicles (* in b ), secondary follicles (SF in b ), tertiary follicles ( c ), and corpora lutea ( d ). e , f Fallopian tube. Neither in the ampulla ( e ) nor in the isthmus ( f ) is CAIV immunostaining observed in the epithelium (Ep) and musculature (M). In the uterus ( g ), endometrial capillaries were CAIV immunoreactive (insert in g ), while no staining is visible in the endometrial epithelium (Ep) and the endometrial stromal cells (S). h Vagina. In the vaginal tissue, no CAIV-immunoreactive cells are observed in the epithelium (Ep) or in the stroma (S). i In kidney as positive control, a strong CAIV signal is visible in tubular epithelium while the negative control of the endometrium ( j ) shows no immunostaining (counterstaining with hematoxylin). Bar, 50 μm.
    Polyclonal Goat Igg Antibody Against Caiv, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+caiv+antibody/Mouse+Carbonic+Anhydrase+IV%2FCA4+Antibody/pmc12060823-69-15-22
    Average 95 stars, based on 1 article reviews
    polyclonal goat igg antibody against caiv - by Bioz Stars, 2026-09
    95/100 stars
      Buy from Supplier

    93
    R&D Systems anti caiv antibody
    <t>CAIV</t> immunostaining of reproductive organs in nonpregnant mice. a–d Ovary. No immunostaining is visible in the mullerian epithelium (ME in a ), ovarian stroma (S in a ), primordial follicles (arrow in a ), primary follicles (* in b ), secondary follicles (SF in b ), tertiary follicles ( c ), and corpora lutea ( d ). e , f Fallopian tube. Neither in the ampulla ( e ) nor in the isthmus ( f ) is CAIV immunostaining observed in the epithelium (Ep) and musculature (M). In the uterus ( g ), endometrial capillaries were CAIV immunoreactive (insert in g ), while no staining is visible in the endometrial epithelium (Ep) and the endometrial stromal cells (S). h Vagina. In the vaginal tissue, no CAIV-immunoreactive cells are observed in the epithelium (Ep) or in the stroma (S). i In kidney as positive control, a strong CAIV signal is visible in tubular epithelium while the negative control of the endometrium ( j ) shows no immunostaining (counterstaining with hematoxylin). Bar, 50 μm.
    Anti Caiv Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+caiv+antibody/Human+Carbonic+Anhydrase+IV%2FCA4+Antibody/pmc11354224-327-1-10
    Average 93 stars, based on 1 article reviews
    anti caiv antibody - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    92
    R&D Systems anti caiv antibodies
    <t>CAIV</t> immunostaining of reproductive organs in nonpregnant mice. a–d Ovary. No immunostaining is visible in the mullerian epithelium (ME in a ), ovarian stroma (S in a ), primordial follicles (arrow in a ), primary follicles (* in b ), secondary follicles (SF in b ), tertiary follicles ( c ), and corpora lutea ( d ). e , f Fallopian tube. Neither in the ampulla ( e ) nor in the isthmus ( f ) is CAIV immunostaining observed in the epithelium (Ep) and musculature (M). In the uterus ( g ), endometrial capillaries were CAIV immunoreactive (insert in g ), while no staining is visible in the endometrial epithelium (Ep) and the endometrial stromal cells (S). h Vagina. In the vaginal tissue, no CAIV-immunoreactive cells are observed in the epithelium (Ep) or in the stroma (S). i In kidney as positive control, a strong CAIV signal is visible in tubular epithelium while the negative control of the endometrium ( j ) shows no immunostaining (counterstaining with hematoxylin). Bar, 50 μm.
    Anti Caiv Antibodies, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+caiv+antibody/Human+Carbonic+Anhydrase+IV%2FCA4+Antibody/pmc11354224-97-3-8
    Average 92 stars, based on 1 article reviews
    anti caiv antibodies - by Bioz Stars, 2026-09
    92/100 stars
      Buy from Supplier

    86
    Danaher Inc caiv
    <t>CAIV</t> immunostaining of reproductive organs in nonpregnant mice. a–d Ovary. No immunostaining is visible in the mullerian epithelium (ME in a ), ovarian stroma (S in a ), primordial follicles (arrow in a ), primary follicles (* in b ), secondary follicles (SF in b ), tertiary follicles ( c ), and corpora lutea ( d ). e , f Fallopian tube. Neither in the ampulla ( e ) nor in the isthmus ( f ) is CAIV immunostaining observed in the epithelium (Ep) and musculature (M). In the uterus ( g ), endometrial capillaries were CAIV immunoreactive (insert in g ), while no staining is visible in the endometrial epithelium (Ep) and the endometrial stromal cells (S). h Vagina. In the vaginal tissue, no CAIV-immunoreactive cells are observed in the epithelium (Ep) or in the stroma (S). i In kidney as positive control, a strong CAIV signal is visible in tubular epithelium while the negative control of the endometrium ( j ) shows no immunostaining (counterstaining with hematoxylin). Bar, 50 μm.
    Caiv, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+caiv+antibody/10__1007_slash_s10750___022___05020___6-69-30-31
    Average 86 stars, based on 1 article reviews
    caiv - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    92
    R&D Systems primary anti caiv antibody
    <t>CAIV</t> immunostaining of reproductive organs in nonpregnant mice. a–d Ovary. No immunostaining is visible in the mullerian epithelium (ME in a ), ovarian stroma (S in a ), primordial follicles (arrow in a ), primary follicles (* in b ), secondary follicles (SF in b ), tertiary follicles ( c ), and corpora lutea ( d ). e , f Fallopian tube. Neither in the ampulla ( e ) nor in the isthmus ( f ) is CAIV immunostaining observed in the epithelium (Ep) and musculature (M). In the uterus ( g ), endometrial capillaries were CAIV immunoreactive (insert in g ), while no staining is visible in the endometrial epithelium (Ep) and the endometrial stromal cells (S). h Vagina. In the vaginal tissue, no CAIV-immunoreactive cells are observed in the epithelium (Ep) or in the stroma (S). i In kidney as positive control, a strong CAIV signal is visible in tubular epithelium while the negative control of the endometrium ( j ) shows no immunostaining (counterstaining with hematoxylin). Bar, 50 μm.
    Primary Anti Caiv Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+caiv+antibody/Human+Carbonic+Anhydrase+IV%2FCA4+Antibody/pmc06333884-670-4-13
    Average 92 stars, based on 1 article reviews
    primary anti caiv antibody - by Bioz Stars, 2026-09
    92/100 stars
      Buy from Supplier

    Image Search Results


    CAIV immunostaining of reproductive organs in nonpregnant mice. a–d Ovary. No immunostaining is visible in the mullerian epithelium (ME in a ), ovarian stroma (S in a ), primordial follicles (arrow in a ), primary follicles (* in b ), secondary follicles (SF in b ), tertiary follicles ( c ), and corpora lutea ( d ). e , f Fallopian tube. Neither in the ampulla ( e ) nor in the isthmus ( f ) is CAIV immunostaining observed in the epithelium (Ep) and musculature (M). In the uterus ( g ), endometrial capillaries were CAIV immunoreactive (insert in g ), while no staining is visible in the endometrial epithelium (Ep) and the endometrial stromal cells (S). h Vagina. In the vaginal tissue, no CAIV-immunoreactive cells are observed in the epithelium (Ep) or in the stroma (S). i In kidney as positive control, a strong CAIV signal is visible in tubular epithelium while the negative control of the endometrium ( j ) shows no immunostaining (counterstaining with hematoxylin). Bar, 50 μm.

    Journal: Cells, Tissues, Organs

    Article Title: Carbonic Anhydrase IV Deficiency Causes Intrauterine Embryonic Loss in Mice

    doi: 10.1159/000544000

    Figure Lengend Snippet: CAIV immunostaining of reproductive organs in nonpregnant mice. a–d Ovary. No immunostaining is visible in the mullerian epithelium (ME in a ), ovarian stroma (S in a ), primordial follicles (arrow in a ), primary follicles (* in b ), secondary follicles (SF in b ), tertiary follicles ( c ), and corpora lutea ( d ). e , f Fallopian tube. Neither in the ampulla ( e ) nor in the isthmus ( f ) is CAIV immunostaining observed in the epithelium (Ep) and musculature (M). In the uterus ( g ), endometrial capillaries were CAIV immunoreactive (insert in g ), while no staining is visible in the endometrial epithelium (Ep) and the endometrial stromal cells (S). h Vagina. In the vaginal tissue, no CAIV-immunoreactive cells are observed in the epithelium (Ep) or in the stroma (S). i In kidney as positive control, a strong CAIV signal is visible in tubular epithelium while the negative control of the endometrium ( j ) shows no immunostaining (counterstaining with hematoxylin). Bar, 50 μm.

    Article Snippet: After rinsing in distilled water, slices were blocked with PBS-glucose-oxidase buffer and incubated with a polyclonal goat IgG antibody against CAIV (AF2414; R&D Systems, Minneapolis, MN, USA) (1:100 in PBS/5% BSA) overnight at 4°C, followed by incubation with biotinylated anti-goat IgG (1:200 in PBS/5% BSA) for 30 min at room temperature.

    Techniques: Immunostaining, Staining, Positive Control, Negative Control

    CAIV immunostaining of mouse embryos at developmental stages 4.5 ( a ), 5.5 ( b ), 6.5 ( c ), and 7.5 dpc ( d ). CAIV immunoreactivity is visible in the blastocyst (B), the visceral endoderm (VE), and the embryonic ectoderm (IE). Corresponding negative controls ( a ′, b ′, c ′, d ′) show no immunostaining. Slides are counterstained with hematoxylin. Bar, 50 μm in a , b , 100 μm in c , d , 100 μm in a ′, b ′, and 160 μm in c ′, d ′.

    Journal: Cells, Tissues, Organs

    Article Title: Carbonic Anhydrase IV Deficiency Causes Intrauterine Embryonic Loss in Mice

    doi: 10.1159/000544000

    Figure Lengend Snippet: CAIV immunostaining of mouse embryos at developmental stages 4.5 ( a ), 5.5 ( b ), 6.5 ( c ), and 7.5 dpc ( d ). CAIV immunoreactivity is visible in the blastocyst (B), the visceral endoderm (VE), and the embryonic ectoderm (IE). Corresponding negative controls ( a ′, b ′, c ′, d ′) show no immunostaining. Slides are counterstained with hematoxylin. Bar, 50 μm in a , b , 100 μm in c , d , 100 μm in a ′, b ′, and 160 μm in c ′, d ′.

    Article Snippet: After rinsing in distilled water, slices were blocked with PBS-glucose-oxidase buffer and incubated with a polyclonal goat IgG antibody against CAIV (AF2414; R&D Systems, Minneapolis, MN, USA) (1:100 in PBS/5% BSA) overnight at 4°C, followed by incubation with biotinylated anti-goat IgG (1:200 in PBS/5% BSA) for 30 min at room temperature.

    Techniques: Immunostaining

    CAIV immunostaining of a representative mouse embryo at 8.5 dpc in overview ( a ) and in higher magnification ( b , c ). A strong immunoreactivity is visible in the amniotic membrane (AM), the yolk sac epithelium (Y), trophoblast giant cells (TGC), the endometrial epithelium (EE), and the developing GT of the embryo (E). Corresponding negative controls ( a ′, b ′, c ′) show no immunostaining. Slides are counterstained with hematoxylin. Bar indicates 200 μm in a and 50 μm in b , c .

    Journal: Cells, Tissues, Organs

    Article Title: Carbonic Anhydrase IV Deficiency Causes Intrauterine Embryonic Loss in Mice

    doi: 10.1159/000544000

    Figure Lengend Snippet: CAIV immunostaining of a representative mouse embryo at 8.5 dpc in overview ( a ) and in higher magnification ( b , c ). A strong immunoreactivity is visible in the amniotic membrane (AM), the yolk sac epithelium (Y), trophoblast giant cells (TGC), the endometrial epithelium (EE), and the developing GT of the embryo (E). Corresponding negative controls ( a ′, b ′, c ′) show no immunostaining. Slides are counterstained with hematoxylin. Bar indicates 200 μm in a and 50 μm in b , c .

    Article Snippet: After rinsing in distilled water, slices were blocked with PBS-glucose-oxidase buffer and incubated with a polyclonal goat IgG antibody against CAIV (AF2414; R&D Systems, Minneapolis, MN, USA) (1:100 in PBS/5% BSA) overnight at 4°C, followed by incubation with biotinylated anti-goat IgG (1:200 in PBS/5% BSA) for 30 min at room temperature.

    Techniques: Immunostaining, Membrane

    CAIV immunostaining of mouse embryos at 9.5 dpc in overview ( a , b ) and in higher magnification ( c–h ). Within the developing embryo ( c , d ), CAIV immunostaining is visible in the gut tube (GT), the floor plate of the neural tube (FP), and the notochord (N). In placenta and extraembryonic tissues ( e–h ), the labyrinthine compartment (LT), the endometrial epithelium (EE), the trophoblast giant cells (TGC), and the yolk sac epithelium (Y) show immunoreactivity. The corresponding negative control ( b ) shows no immunostaining (counterstaining with hematoxylin). Bar = 500 μm in a , b and 50 μm in c–h .

    Journal: Cells, Tissues, Organs

    Article Title: Carbonic Anhydrase IV Deficiency Causes Intrauterine Embryonic Loss in Mice

    doi: 10.1159/000544000

    Figure Lengend Snippet: CAIV immunostaining of mouse embryos at 9.5 dpc in overview ( a , b ) and in higher magnification ( c–h ). Within the developing embryo ( c , d ), CAIV immunostaining is visible in the gut tube (GT), the floor plate of the neural tube (FP), and the notochord (N). In placenta and extraembryonic tissues ( e–h ), the labyrinthine compartment (LT), the endometrial epithelium (EE), the trophoblast giant cells (TGC), and the yolk sac epithelium (Y) show immunoreactivity. The corresponding negative control ( b ) shows no immunostaining (counterstaining with hematoxylin). Bar = 500 μm in a , b and 50 μm in c–h .

    Article Snippet: After rinsing in distilled water, slices were blocked with PBS-glucose-oxidase buffer and incubated with a polyclonal goat IgG antibody against CAIV (AF2414; R&D Systems, Minneapolis, MN, USA) (1:100 in PBS/5% BSA) overnight at 4°C, followed by incubation with biotinylated anti-goat IgG (1:200 in PBS/5% BSA) for 30 min at room temperature.

    Techniques: Immunostaining, Negative Control

    Litter size and sex distribution in heterozygous and CAIV knockout mating. a Mating of CAIV knockout mice ( n = 17 litters) results in a significant reduction of litter size compared to heterozygous mating ( n = 31 litters). b Homozygous CAIV knockout mating results in a non-mendalian sex distribution of the 54 CAIV knockout pubs analyzed (74% male and 26% female instead of 50% each). c In heterozygous mating, the 164 pups analyzed show an enhanced number of wild-type (31% instead of 25% expected) and heterozygous genotype (62% instead of 50% expected), whereas the number of CAIV knockout pups is significantly reduced (7% instead of 25% expected). d A non-mendelian sex distribution is also observed in the 12 CAIV knockout pups (shown in c ) resulting from heterozygous mating (67% male and 33% female instead of 50% each), while there is a slight preponderance of female pups in both the 50 resulting wild-type (36% male vs. 64% female) and the 102 resulting CAIV heterozygous pups (46% male vs. 54% female). e On 9.5 dpc, number of implantation chambers is similar in heterozygous ( n = 3) and CAIV knockout ( n = 5) mating. The sex distribution of embryos is slightly shifted to female in both experimental groups, showing a higher percentage of female embryos in heterozygous mating in total ( n = 26; 40% male vs. 60% female) as well as in CAIV knockout embryos resulting from heterozygous mating (40% male vs. 60% female). f Additionally, CAIV knockout mating results in a higher percentage of female embryos on day 9.5 of pregnancy ( n = 21; 43% male vs. 57% female).

    Journal: Cells, Tissues, Organs

    Article Title: Carbonic Anhydrase IV Deficiency Causes Intrauterine Embryonic Loss in Mice

    doi: 10.1159/000544000

    Figure Lengend Snippet: Litter size and sex distribution in heterozygous and CAIV knockout mating. a Mating of CAIV knockout mice ( n = 17 litters) results in a significant reduction of litter size compared to heterozygous mating ( n = 31 litters). b Homozygous CAIV knockout mating results in a non-mendalian sex distribution of the 54 CAIV knockout pubs analyzed (74% male and 26% female instead of 50% each). c In heterozygous mating, the 164 pups analyzed show an enhanced number of wild-type (31% instead of 25% expected) and heterozygous genotype (62% instead of 50% expected), whereas the number of CAIV knockout pups is significantly reduced (7% instead of 25% expected). d A non-mendelian sex distribution is also observed in the 12 CAIV knockout pups (shown in c ) resulting from heterozygous mating (67% male and 33% female instead of 50% each), while there is a slight preponderance of female pups in both the 50 resulting wild-type (36% male vs. 64% female) and the 102 resulting CAIV heterozygous pups (46% male vs. 54% female). e On 9.5 dpc, number of implantation chambers is similar in heterozygous ( n = 3) and CAIV knockout ( n = 5) mating. The sex distribution of embryos is slightly shifted to female in both experimental groups, showing a higher percentage of female embryos in heterozygous mating in total ( n = 26; 40% male vs. 60% female) as well as in CAIV knockout embryos resulting from heterozygous mating (40% male vs. 60% female). f Additionally, CAIV knockout mating results in a higher percentage of female embryos on day 9.5 of pregnancy ( n = 21; 43% male vs. 57% female).

    Article Snippet: After rinsing in distilled water, slices were blocked with PBS-glucose-oxidase buffer and incubated with a polyclonal goat IgG antibody against CAIV (AF2414; R&D Systems, Minneapolis, MN, USA) (1:100 in PBS/5% BSA) overnight at 4°C, followed by incubation with biotinylated anti-goat IgG (1:200 in PBS/5% BSA) for 30 min at room temperature.

    Techniques: Knock-Out